|Overview: What is CREST?
CREST Patient Stories
CREST is a form of Systemic Sclerosis (scleroderma) which is characterized by Calcinosis (calcium deposits), usually in the fingers; Raynaud's;loss of muscle control of the Esophagus, which can cause difficulty swallowing; Sclerodactyly, a tapering deformity of the bones of the fingers; and Telangiectasia, small red spots on the skin of the fingers, face, or inside of the mouth. (Also see What is Scleroderma?, Types of Scleroderma and Systemic Symptoms)
It takes only two of the five CREST symptoms for a diagnosis of CREST (either "pure" or "plus") to be made. For example, a patient with Calcinosis and Raynaud's would have CREST (which for precision may also be written as CRest, but it is CREST nonetheless.)
CREST Syndrome. "Patients with CREST syndrome are a subset of patients with scleroderma…" Medscape.
"Pure"CREST — by itself: "Pure" CREST is diagnosed when patients have two or more symptoms of CREST but they do not meet the criteria for either Limited or Diffuse Scleroderma. That is, they must not have tight skin above their wrists, and if there is tight skin on their fingers, they must not have either pitting digital ulcers or lung fibrosis.
"Plus" CREST — along with. When CREST symptoms appear along with another form of Scleroderma, it is referred to as, for example, "Limited Scleroderma plus CREST" or "Diffuse Scleroderma plus CREST." A person may also have any other autoimmune disease " plus CREST."
Although some doctors still believe CREST is a useful subcategory, the existing research studies have been unable to predict consistently how (or whether) the disease will progress to Diffuse Systemic Scleroderma in any specific individual.
Primary biliary cirrhosis accompanied by CREST syndrome. Second Department of Propedeutic Surgery, Medical School University of Athens, Greece. South Med J 2002 Sep;95(9):1058-9. PubMed, (Also see Liver Involvement
CRST Syndrome In 1964, Winterbauer defined and named the CRST syndrome, a variant of scleroderma, when he was a Johns Hopkins medical student. Bull. Johns Hopkins Hosp. 114: 361-383, 1964.
CREST First Defined : In 1979, CRST was expanded to CREST by Shulman's group, also at Johns Hopkins, who added esophageal involvement to the cardinal manifestations. Arch Intern Med 1979 Nov;139(11):1240-4.
Antibodies: Anticentromere Antibodies (ACA) are the most common antibodies found in CREST Syndrome. ISN.
Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases). the low prevalence of ACA observed in this survey, when compared to American, European and Japanese studies, is probably due to ethnic variation in frequency of ANA. Indeed, low rates or absence of ACA have been reported in south-African, Afro-American, Indian, and Thai studies. (PubMed) Ann Biol Clin (Paris). 2007 May-Jun;65(3):291-7.
Granulomatous uveitis, CREST syndrome, and primary biliary cirrhosis. Our case report illustrates an association between ocular and hepatic diseases, which may be entirely coincidental but could, nevertheless, encourage further investigation for a common immunological pathway. Br J Ophthalmol 2000;84:546. (Also see Liver Involvement and Uveitis)
CREST Patient and Caregiver Stories. Read personal stories from CREST patients and caregivers of CREST patients. ISN.
Scleroderma Photos. ISN.
Skin Involvement. ISN.
Reading Voices of Scleroderma Books: Diana Kramer.
Sharing Scleroderma Awareness Bracelets: Deb Martin, Brenda Miller, Vickie Risner.
Thanks to UNITED WAY donors of Central New Mexico and Snohomish County!
Patricia Ann Black: Marilyn Currier, Shelley Ensz, Richard Howitt, Gerald and Pat Ivanejko, Juno Beach Condo Association, Keith and Rosalyn Miller, and Elaine Wible.
Gayle Hedlin: Daniel and Joann Pepper and Nancy Smithberg.
Janet Paulmenn: Anonymous, Shelley Blaser, Susan Book, Dennis and Pat Clayton, Grace Cunha, Cindy Dorio, Shelley Ensz, Nancy Falkenhagen, Jo Frowde, Margaret Hollywood, Karen Khalaf and Family, Susan Kvarantan, Bradley Lawrence, Jillyan Little, Michele Maxson, John Moffett, Joan-Marie Permison, John Roberts, Margaret Roof, and Maryellen Ryan.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to:
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA
Email [email protected] to request our Welcome email, or to report bad links or to update this page content.